This programme provides funding for IV iron infusions for patients who meet the PHARMAC special authority criteria for prescribing subsidised ferric carboxymaltose (Ferinject) in the community.
The infusion is to be provided in the community by the patient’s general practitioner.
Please consider the underlying cause of the iron deficiency anaemia and investigate as per best practice. For guidance on diagnosing and managing iron deficiency anaemia, see Anaemia on full blood count: investigating beyond the pale (in the resources section below).
Your Pinnacle Services Contract applies to this service. By claiming for this service, you have indicated that you have read and agreed to the business rules set out here.
This is NOT a clinical guideline.
All Pinnacle practices in the Te Whatu Ora Lakes area.
Patients who meet the special authority criteria for subsidised ferric carboxymaltose (Ferinject). Please refer to the PHARMAC website for special authority criteria for Ferinject (SA1840).
Patients domiciled in Te Whatu Ora Lakes area.
Patients not domiciled in Te Whatu Ora Lakes area.
Contraindications to using Ferinject in patients:
NB: allergic reactions are more common in people with a history of inflammatory diseases such as asthma, eczema and rheumatoid arthritis. Close observation is recommended for all patients whether or not they have had an iron infusion in the past. (Please see the link to Intravenous iron – safe prescribing – calculate and measure in our resources section below.)
Please make your claim by selecting Iron Infusion from the list of eligible services for indici practices or via advanced form for Medtech practices
Iron infusion: $150 (GST incl)
Please be aware the claim is all inclusive of the GP consultation, administration of the infusion, observation time and consumables.
Please include the Pharmac SA number with your claim
Practices are required to provide sufficiently detailed consultation notes to determine appropriate use of funding.
Please ensure the condition that required the iron infusion is documented.
Please include the Pharmac SA number with your claim
No. A patient co-payment cannot be charged. This service funds the administration of the infusion and there is no cost for the infusion to the patient, provided entry criteria are achieved. The funding for the service includes the co-payment for the initial GP consultation followed by the nurse administration of the infusion.
This service does not include the cost of the medication on special authority, this is the responsibility of the patient to purchase.
The service is funded by Te Whatu Ora.
Practice systems support team
practice.support@pinnacle.health.nz
07 838 5983
Sally Newell, Regional Support Manager - Clinical Contracts
sally.newell@pinnacle.health.nz
021 150 8788
A range of guides to assist when using the iron infusion programme.
Pinnacle has developed a rural chest pain assessment method that allows low-risk patients in rural communities to be safely assessed and managed by their general practice, rather than travelling significant distances to hospital - often needlessly.
Read morePathlab has reported BNP levels using the Triage Method and using EDTA plasma as the preferred sample type. The current reference interval is 0-100 ng/L. From 23 December 2024, the current BNP method will be replaced by NT-proBNP. This method is more specific than BNP, as NT-proBNP has a longer half-life and is less influenced by factors like obesity or kidney function.
Read moreTreatment of patients with suspected ACC related DVT with a Wells Score of >= 2 or a positive D-dimer.
View detailsA range of guides to assist when using the iron infusion programme.